المؤلفون: O. S. Fedorova, Y. V. Kovshirina, A. E. Kovshirina, M. M. Fedotova, I. A. Deev, F. I. Petrovskiy, A. V. Filimonov, A. I. Dmitrieva, L. A. Kudyakov, I. V. Saltykova, Е. В. Михалев, P. Odermatt, L. M. Ogorodova

المصدر: Бюллетень сибирской медицины, Vol 15, Iss 5, Pp 147-158 (2017)

مصطلحات موضوعية: инвазия opisthorchis felineus, злокачественные новообразования гепатобилиарной системы, заболеваемость, эпидемиология, Medicine

وصف الملف: electronic resource

Relation: https://bulletin.ssmu.ru/jour/article/view/744; https://doaj.org/toc/1682-0363; https://doaj.org/toc/1819-3684

URL الوصول: https://doaj.org/article/5aeb5984f667418bbc6a783c344d7f69

المؤلفون: E. V. Loshkova, I. V. Doroshenko, T. S. Lyulka, Y. S. Rafikov, V. A. Zhelev, S. P. Ermolenko, E. V. Mikhalev, I. R. Grishkevich, N. E. Melnikov, A. L. Solnyshko, A. A. Bogunetsky, E. I. Kondratieva, A. I. Khavkin, N. D. Odinaeva, E. I. Makarevich, Е. В. Лошкова, И. В. Дорошенко, Т. С. Люлька, Ю. С. Рафикова, В. А. Желев, С. П. Ермоленко, Е. В. Михалев, И. Р. Гришкевич, Н. Е. Мельников, А. Л. Солнышко, А. А. Богунецкий, Е. И. Кондратьева, А. И. Хавкин, Н. Дж. Одинаева, Е. И. Макаревич

المصدر: Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics); Том 68, № 6 (2023); 85-93 ; Российский вестник перинатологии и педиатрии; Том 68, № 6 (2023); 85-93 ; 2500-2228 ; 1027-4065

مصطلحات موضوعية: негативные последствия для плода, new psychoactive substances, “bath salts”, pregnancy, prematurity, bone fractures, negative consequences for the fetus, новые психоактивные вещества, «соли», беременность, недоношенность, переломы костей

وصف الملف: application/pdf

Relation: https://www.ped-perinatology.ru/jour/article/view/1910/1439; Palamar J.J., Su M.K., Hoffman R.S. Characteristics of novel psychoactive substance exposures reported to New York City Poison Center, 2011–2014. Am J Drug Alcohol Abuse 2016; 42(1): 39–47. DOI:10.3109/00952990.2015.1106551; Wood K.E. Exposure to bath salts and synthetic tetrahydrocannabinol from 2009 to 2012 in the United States. J Pediatr 2013; 163(1): 213–216. DOI:10.1016/j.jpeds.2012.12.056; Ebrahim S.H., Gfroerer J. Pregnancy-related substance use in the United States during 1996–1998. Obstet Gynecol 2003; 101(2): 374–379. DOI:10.1016/s0029–7844(02)02588–7; Greenfield S.F., Manwani S.G., Nargiso J.E. Epidemiology of substance use disorders in women. Obstet Gynecol Clin North Am 2003; 30(3): 413–446. DOI:10.1016/s0889–8545(03)00072-x; Chang J.C., Holland C.L., Tarr J.A., Rubio D., Rodriguez K.L., Kraemer K.L. et al. Perinatal Illicit Drug and Marijuana Use. Am J Health Promot 2017; 31(1): 35–42. DOI:10.4278/ajhp.141215-QUAL-625; Gómez-Ruiz L.M., Marchei E., Rotolo M.C., Brunetti P., Mannocchi G., Acosta-López A. et al. Prevalence of Licit and Illicit Drugs Use during Pregnancy in Mexican Women. Pharmaceuticals (Basel) 2022; 15(3): 382. DOI:10.3390/ph15030382; Gunn J.K., Rosales C.B., Center K.E., Nuñez A., Gibson S.J., Christ C., Ehiri J.E. Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis. BMJ Open. 2016; 6(4): e009986. DOI:10.1136/bmjopen-2015–009986; Marchand G., Masoud A.T., Govindan M., Ware K., King A., Ruther S. et al. Birth Outcomes of Neonates Exposed to Marijuana in Utero: A Systematic Review and Meta-analysis. JAMA Netw Open 2022; 5(1): e2145653. DOI:10.1001/jamanetworkopen.2021.45653; Reece A.S., Hulse G.K. Epidemiological overview of multidimensional chromosomal and genome toxicity of cannabis exposure in congenital anomalies and cancer development. Sci Rep 2021; 11(1): 13892. DOI:10.1038/s41598–021–93411–5; Kalix P. A constituent of khat leaves with amphetamine-like releasing properties. Eur J Pharmacol 1980; 68(2): 213–215. DOI:10.1016/0014–2999(80)90326-x; Hadlock G.C., Webb K.M., McFadden L.M., Chu P.W., Ellis J.D., Allen S.C. et al. 4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse. J Pharmacol Exp Ther 2011; 339(2): 530–536. DOI:10.1124/jpet.111.184119; Pehek E.A., Schechter M.D., Yamamoto B.K. Effects of cathinone and amphetamine on the neurochemistry of dopamine in vivo. Neuropharmacology 1990; 29(12): 1171–1176. DOI:10.1016/0028–3908(90)90041-o; den Hollander B., Sundström M., Pelander A., Ojanperä I., Mervaala E., Korpi E.R., Kankuri E. Keto amphetamine toxicity-focus on the redox reactivity of the cathinone designer drug mephedrone. Toxicol Sci 2014; 141(1): 120–131. DOI:10.1093/toxsci/kfu108; López-Arnau R., Martínez-Clemente J., Rodrigo T., Pubill D., Camarasa J., Escubedo E. Neuronal changes and oxidative stress in adolescent rats after repeated exposure to mephedrone. Toxicol Appl Pharmacol 2015; 286(1): 27–35. DOI:10.1016/j.taap.2015.03.015; Buzhdygan T.P., Rodrigues C.R., McGary H.M., Khan J.A., Andrews A.M., Rawls S.M., Ramirez S.H. The psychoactive drug of abuse mephedrone differentially disrupts blood-brain barrier properties. J Neuroinflammation 2021; 18(1): 63. DOI:10.1186/s12974–021–02116-z; Martínez-Clemente J., López-Arnau R., Abad S., Pubill D., Escubedo E., Camarasa J. Dose and time-dependent selective neurotoxicity induced by mephedrone in mice. PLoS One 2014; 9(6): e99002. DOI:10.1371/journal.pone.0099002; Tarkowski P., Jankowski K., Budzyńska B., Biała G., Boguszewska-Czubara A. Potential pro-oxidative effects of single dose of mephedrone in vital organs of mice. Pharmacol Rep 2018; 70(6): 1097–1104. DOI:10.1016/j.pharep.2018.05.010; Naseri G., Fazel A., Golalipour M.J., Haghir H., Sadeghian H., Mojarrad M. et al. Exposure to mephedrone during gestation increases the risk of stillbirth and induces hippocampal neurotoxicity in mice offspring. Neurotoxicol Teratol 2018; 67: 10–17. DOI:10.1016/j.ntt.2018.03.001; Adám A., Gerecsei L.I., Lepesi N., Csillag A. Apoptotic effects of the ‘designer drug’ methylenedioxypyrovalerone (MDPV) on the neonatal mouse brain. Neurotoxicology 2014; 44: 231–236. DOI:10.1016/j.neuro.2014.07.004; Yang Z., Klionsky D.J. Mammalian autophagy: core molecular machinery and signaling regulation. Curr Opin Cell Biol 2010; 22(2): 124–131. DOI:10.1016/j.ceb.2009.11.014; Yang Z.J., Chee C.E., Huang S., Sinicrope F. Autophagy modulation for cancer therapy. Cancer Biol Ther 2011; 11(2): 169–176. DOI:10.4161/cbt.11.2.14663; Valente M.J., Amaral C., Correia-da-Silva G., Duarte J.A., Bastos M.L., Carvalho F. et al. Methylone and MDPV activate autophagy in human dopaminergic SH-SY5Y cells: a new insight into the context of β-keto amphetamines-related neurotoxicity. Arch Toxicol 2017; 91(11): 3663–3676. DOI:10.1007/s00204–017–1984-z; Matsunaga T., Morikawa Y., Kamata K., Shibata A., Miyazono H., Sasajima Y. et al. α-Pyrrolidinononanophenone provokes apoptosis of neuronal cells through alterations in antioxidant properties. Toxicology 2017; 386: 93–102. DOI:10.1016/j.tox.2017.05.017; Siedlecka-Kroplewska K., Wrońska A., Stasiłojć G., Kmieć Z. The Designer Drug 3-Fluoromethcathinone Induces Oxidative Stress and Activates Autophagy in HT22 Neuronal Cells. Neurotox Res 2018; 34: 388–400. DOI:10.1007/S12640– 018–9898-Y; Angoa-Pérez M., Kane M.J., Francescutti D.M., Sykes K.E., Shah M.M., Mohammed A.M. et al. Mephedrone, an abused psychoactive component of ‘bath salts’ and methamphetamine congener, does not cause neurotoxicity to dopamine nerve endings of the striatum. J Neurochem 2012; 120(6): 1097–1107. DOI:10.1111/j.1471–4159.2011.07632. x; Marusich J.A., Gay E.A., Stewart D.A., Blough B.E. Sex differences in inflammatory cytokine levels following synthetic cathinone self-administration in rats. Neurotoxicology 2022; 88: 65–78. DOI:10.1016/j.neuro.2021.11.002; Kim O.H., Jeon K.O., Jang E.Y. Alpha-pyrrolidinopentiothiophenone (α-PVT) activates the TLR-NF-κB-MAPK signaling pathway and proinflammatory cytokine production and induces behavioral sensitization in mice. Pharmacol Biochem Behav 2022; 221: 173484. DOI:10.1016/j.pbb.2022.173484; Pichini S., Rotolo M.C., García J., Girona N., Leal L., García-Algar O., Pacifici R. Neonatal withdrawal syndrome after chronic maternal consumption of 4-methylethcathinone. Forensic Sci Int 2014; 245: e33–е35. DOI:10.1016/j.forsciint.2014.10.027; Adamowicz P., Hydzik P. Fetal death associated with the use of 3,4-MDPHP and α-PHP. Clin Toxicol (Phila) 2019; 57(2): 112–116. DOI:10.1080/15563650.2018.1502443; Grapp M., Kaufmann C., Ebbecke M. Toxicological investigation of forensic cases related to the designer drug 3,4-methylenedioxypyrovalerone (MDPV): Detection, quantification and studies on human metabolism by GC-MS. Forensic Sci Int 2017; 273: 1–9. DOI:10.1016/j.forsciint.2017.01.021; https://www.ped-perinatology.ru/jour/article/view/1910

الاتاحة: https://www.ped-perinatology.ru/jour/article/view/1910
https://doi.org/10.21508/1027-4065-68-6-85-93

المؤلفون: Elena V. Loshkova, Ivan V. Doroshenko, Tatiana S. Liulka, Anatoly I. Khavkin, Elena I. Kondratieva, Nuriniso D. Odinaeva, Yulia S. Rafikova, Viktor A. Zhelev, Andrey L. Solnyshko, Evgeniy V. Mikhalev, Sergey P. Ermolenko, Ivan R. Grishkevich, Nikolay E. Melnikov, Anton A. Bohunetsky, Elizaveta I. Makarevich, Е. В. Лошкова, И. В. Дорошенко, Т. С. Люлька, А. И. Хавкин, Е. И. Кондратьева, Н. Д. Одинаева, Ю. С. Рафикова, В. А. Желев, А. Л. Солнышко, Е. В. Михалев, С. П. Ермоленко, И. Р. Гришкевич, Н. Е. Мельников, А. А. Богунецкий, Е. И. Макаревич

المساهمون: Not specified., Отсутствует.

المصدر: Pediatric pharmacology; Том 20, № 6 (2023); 546–556 ; Педиатрическая фармакология; Том 20, № 6 (2023); 546–556 ; 2500-3089 ; 1727-5776

مصطلحات موضوعية: негативные последствия для новорожденного, “salts”, pregnancy, prematurity, bone fractures, negative outcomes for newborn, «соли», беременность, недоношенность, переломы костей

وصف الملف: application/pdf

Relation: https://www.pedpharma.ru/jour/article/view/2376/1546; Palamar JJ, Su MK, Hoffman RS. Characteristics of novel psychoactive substance exposures reported to New York City Poison Center, 2011–2014. Am J Drug Alcohol Abuse. 2016;42(1):39–47. doi: https://doi.org/10.3109/00952990.2015.1106551; Wood KE. Exposure to bath salts and synthetic tetrahydrocannabinol from 2009 to 2012 in the United States. J Pediatr. 2013;163(1):213–216. doi: https://doi.org/10.1016/j.jpeds.2012.12.056; Ebrahim SH, Gfroerer J. Pregnancy-related substance use in the United States during 1996-1998. Obstet Gynecol. 2003;101(2):374–379. doi: https://doi.org/10.1016/s0029-7844(02)02588-7; Greenfield SF, Manwani SG, Nargiso JE. Epidemiology of substance use disorders in women. Obstet Gynecol Clin North Am. 2003;30(3):413–446. doi: https://doi.org/10.1016/s0889-8545(03)00072-x; Chang JC, Holland CL, Tarr JA, et al. Perinatal Illicit Drug and Marijuana Use. Am J Health Promot. 2017;31(1):35–42. doi: https://doi.org/10.4278/ajhp.141215-QUAL-625; Gómez-Ruiz LM, Marchei E, Rotolo MC, et al. Prevalence of Licit and Illicit Drugs Use during Pregnancy in Mexican Women. Pharmaceuticals (Basel). 2022;15(3):382. doi: https://doi.org/10.3390/ph15030382; Gunn JK, Rosales CB, Center KE, et al. Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis. BMJ Open. 2016;6(4):e009986. doi: https://doi.org/10.1136/bmjopen-2015-009986; Marchand G, Masoud AT, Govindan M, et al. Birth Outcomes of Neonates Exposed to Marijuana in Utero: A Systematic Review and Meta-analysis. JAMA Netw Open. 2022;5(1):e2145653. doi: https://doi.org/10.1001/jamanetworkopen.2021.45653; Reece AS, Hulse GK. Epidemiological overview of multidimensional chromosomal and genome toxicity of cannabis exposure in congenital anomalies and cancer development. Sci Rep. 2021;11(1):13892. doi: https://doi.org/10.1038/s41598-021-93411-5; Kalix P. A constituent of khat leaves with amphetamine-like releasing properties. Eur J Pharmacol. 1980;68(2):213–215. doi: https://doi.org/10.1016/0014-2999(80)90326-x; den Hollander B, Sundström M, Pelander A, et al. Keto amphetamine toxicity-focus on the redox reactivity of the cathinone designer drug mephedrone. Toxicol Sci. 2014;141(1):120–131. doi: https://doi.org/10.1093/toxsci/kfu108; López-Arnau R, Martínez-Clemente J, Rodrigo T, et al. Neuronal changes and oxidative stress in adolescent rats after repeated exposure to mephedrone. Toxicol Appl Pharmacol. 2015;286(1):27–35. doi: https://doi.org/10.1016/j.taap.2015.03.015; Buzhdygan TP, Rodrigues CR, McGary HM, et al. The psychoactive drug of abuse mephedrone differentially disrupts bloodbrain barrier properties. J Neuroinflammation. 2021;18(1):63. doi: https://doi.org/10.1186/s12974-021-02116-z; Martínez-Clemente J, López-Arnau R, Abad S, et al. Dose and time-dependent selective neurotoxicity induced by mephedrone in mice. PLoS One. 2014;9(6):e99002. doi: https://doi.org/10.1371/journal.pone.0099002; Tarkowski P, Jankowski K, Budzyńska B, et al. Potential prooxidative effects of single dose of mephedrone in vital organs of mice. Pharmacol Rep. 2018;70(6):1097–1104. doi: https://doi.org/10.1016/j.pharep.2018.05.010; Siedlecka-Kroplewska K, Szczerba A, Lipinska A, et al. 3-Fluoromethcathinone, a structural analog of mephedrone, inhibits growth and induces cell cycle arrest in HT22 mouse hippocampal cells. J Physiol Pharmacol. 2014;65(2):241–246; Naseri G, Fazel A, Golalipour MJ, et al. Exposure to mephedrone during gestation increases the risk of stillbirth and induces hippocampal neurotoxicity in mice offspring. Neurotoxicol Teratol. 2018;67:10–17. doi: https://doi.org/10.1016/j.ntt.2018.03.001; Adám A, Gerecsei LI, Lepesi N, Csillag A. Apoptotic effects of the ‘designer drug’ methylenedioxypyrovalerone (MDPV) on the neonatal mouse brain. Neurotoxicology. 2014;44:231–236. doi: https://doi.org/10.1016/j.neuro.2014.07.004; Yang Z, Klionsky DJ. Mammalian autophagy: core molecular machinery and signaling regulation. Curr Opin Cell Biol. 2010;22(2):124–131. doi: https://doi.org/10.1016/j.ceb.2009.11.014; Yang ZJ, Chee CE, Huang S, Sinicrope F. Autophagy modulation for cancer therapy. Cancer Biol Ther. 2011;11(2):169–176. doi: https://doi.org/10.4161/cbt.11.2.14663; Valente MJ, Amaral C, Correia-da-Silva G, et al. Methylone and MDPV activate autophagy in human dopaminergic SH-SY5Y cells: a new insight into the context of β-keto amphetamines-related neurotoxicity. Arch Toxicol. 2017;91(11):3663–3676. doi: https://doi.org/10.1007/s00204-017-1984-z; Matsunaga T, Morikawa Y, Kamata K, et al. α-Pyrrolidinononanophenone provokes apoptosis of neuronal cells through alterations in antioxidant properties. Toxicology. 2017;386:93–102. doi: https://doi.org/10.1016/j.tox.2017.05.017; Siedlecka-Kroplewska K, Wrońska A, Stasiłojć G, et al. The Designer Drug 3-Fluoromethcathinone Induces Oxidative Stress and Activates Autophagy in HT22 Neuronal Cells. Neurotox Res. 2018;34(3):388–400. doi: https://doi.org/10.1007/s12640-018-9898-y; Angoa-Pérez M, Kane MJ, Francescutti DM, et al. Mephedrone, an abused psychoactive component of ‘bath salts’ and methamphetamine congener, does not cause neurotoxicity to dopamine nerve endings of the striatum. J Neurochem. 2012;120(6):1097–1107. doi: https://doi.org/10.1111/j.1471-4159.2011.07632.x; Marusich JA, Gay EA, Stewart DA, Blough BE. Sex differences in inflammatory cytokine levels following synthetic cathinone self-administration in rats. Neurotoxicology. 2022;88:65–78. doi: https://doi.org/10.1016/j.neuro.2021.11.002; Kim OH, Jeon KO, Jang EY. Alpha-pyrrolidinopentiothiophenone (α-PVT) activates the TLR-NF-κB-MAPK signaling pathway and proinflammatory cytokine production and induces behavioral sensitization in mice. Pharmacol Biochem Behav. 2022;221:173484. doi: https://doi.org/10.1016/j.pbb.2022.173484; Pichini S, Rotolo MC, García J, et al. Neonatal withdrawal syndrome after chronic maternal consumption of 4-methylethcathinone. Forensic Sci Int. 2014;245:e33–e35. doi: https://doi.org/10.1016/j.forsciint.2014.10.027; Adamowicz P, Hydzik P. Fetal death associated with the use of 3,4-MDPHP and α-PHP. Clin Toxicol (Phila). 2019;57(2):112–116. doi: https://doi.org/10.1080/15563650.2018.1502443; Grapp M, Kaufmann C, Ebbecke M. Toxicological investigation of forensic cases related to the designer drug 3,4-methylenedioxypyrovalerone (MDPV): Detection, quantification and studies on human metabolism by GC-MS. Forensic Sci Int. 2017;273:1–9. doi: https://doi.org/10.1016/j.forsciint.2017.01.021; Adamowicz P, Gil D, Skulska A, Tokarczyk B. Analysis of MDPV in blood--determination and interpretation. J Anal Toxicol. 2013;37(5):308–312. doi: https://doi.org/10.1093/jat/bkt025; Kalapos MP. 3,4-methylene-dioxy-pyrovalerone (MDPV) epidemic? Orv Hetil. 2011;152(50):2010–2019. doi: https://doi.org/10.1556/OH.2011.29259; Strange LG, Kochelek K, Keasling R, et al. The pharmacokinetic profile of synthetic cathinones in a pregnancy model. Neurotoxicol Teratol. 2017;63:9–13. doi: https://doi.org/10.1016/j.ntt.2017.08.001; Stewart JL, Meeker JE. Fetal and infant deaths associated with maternal methamphetamine abuse. J Anal Toxicol. 1997;21(6):515–517. doi: https://doi.org/10.1093/jat/21.6.515; https://www.pedpharma.ru/jour/article/view/2376

الاتاحة: https://www.pedpharma.ru/jour/article/view/2376
https://doi.org/10.15690/pf.v20i6.2703

المؤلفون: G. N. Yankinа, L. V. Gorlenko, E. V. Loshkova, E. I. Kondratyeva, A. A. Terentyeva, V. A. Zhelev, E. V. Mikhalev, E. Yu. Tyuteva, T. A. Shemyakinа, T. V. Davydova, E. V. Golikova, T. S. Krivonogova, N. A. Barabash, Yu, S. Rafikova, N. A. Ryzhakova, A. L. Solnyshko, Г. Н. Янкина, Л. В. Горленко, Е. В. Лошкова, Е. И. Кондратьева, А. А. Терентьева, В. А. Желев, Е. В. Михалев, Е. Ю. Тютева, Т. А. Шемякина, Т. В. Давыдова, Е. В. Голикова, Т. С. Кривоногова, Н. А. Барабаш, Ю. С. Рафикова, Н. А. Рыжакова, А. Л. Солнышко

المصدر: Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics); Том 66, № 5 (2021); 135-140 ; Российский вестник перинатологии и педиатрии; Том 66, № 5 (2021); 135-140 ; 2500-2228 ; 1027-4065

مصطلحات موضوعية: макроцитарная анемия, enteropathy, allergic inflammation, macrocytic anemia, энтеропатия, аллергическое воспаление

وصف الملف: application/pdf

Relation: https://www.ped-perinatology.ru/jour/article/view/1493/1151; Muraro A., Werfel T., Hoffmann-Sommergruber K., Roberts G., Beyer K., Bindslev-Jensen C. et al. EAACI food allergy and anaphylaxis guidelines: diagnosis and management of food allergy. Allergy 2014; 69(8): 1008–1025. DOI:10.1111/all.12429; Koletzko S., Niggemann B., Arato A., Dias J.A., Heuschkel R., Husby S., et al. European Society of Pediatric Gastroenterology, Hepatology, and Nutrition. Diagnostic approach and management of cow’s-milk protein allergy in infants and children: ESPGHAN GI Committee practical guidelines. J Pediatr Gastroenterol Nutr 2012; 55(2): 221–229. DOI:10.1097/MPG.0b013e31825c9482; Caubet J.C., Szajewska H., Shamir R., Nowak-Wegrzyn A. Non-IgEmediated gastrointestinal food allergies in children. Pediatr Allergy Immunol 2017; 28(1): 6–17. DOI:10.1111/pai.12659; Макарова С.Г., Намазова-Баранова Л.С., Вишнева Е.А., Ерешко О.А., Гордеева И.Г. Гастроинтестинальная пищевая аллергия у детей. Вопросы современной педиатрии 2017; 16(3): 202–212.; Вишнева Е.А., Намазова-Баранова Л.С., Макарова С.Г., Алексеева А.А., Эфендиева К.Е., Левина Ю.Г. и др. Пищевая аллергия к белкам пшеницы. Трудности диагностики и лечения. Педиатрическая фармакология 2015; 12(4): 429–434. DOI:10.15690/pf.v12i4.1424.; Ванденплас И., Захарова И.Н., Дмитриева Ю.А. Комментарии к практическим рекомендациям ESPGHAN по диагностике и лечению аллергии к белкам коровьего молока у детей грудного и раннего возраста. Consilium Medicum. Педиатрия (Прил.). 2016; 3: 7–12.; Намазова-Баранова Л.С., Сновская М.А., Митюшин И.Л., Кожевникова О.В., Батырова А.С. Особенности диагностики аллергии у детей. Вестник РАМН 2017; 72(1): 33–41.; Новикова В.П., Похлебкина А.А. Энтероколитический синдром, индуцированный пищевыми белками, в практике педиатра. Педиатр 2019; 10 (2): 69–74.; Altinel Acoglu E., Akcaboy M., Melek Oguz M., Kilic M., Zorlu P., Senel S. Hypoalbuminemia and Malnutrition Associated with Cow’s Milk Allergy: A Case Report. Iran Red Crescent Med J 2016; 18(6): e34810. DOI:10.5812/ircmj.34810; Kvammen J.A., Thomassen R.A., Eskerud M.B., Rugtveit J., Henriksen C. Micronutrient Status and Nutritional Intake in 0- to 2-Year-old Children Consuming a Cows’ Milk Exclusion Diet. J Pediatr Gastroenterol Nutr 2018; 66(5): 831–837. DOI:10.1097/MPG.0000000000001942; Allen L.H., Miller J.W., de Groot L., Rosenberg I.H., Smith A.D., Refsum H., Raiten D.J. Biomarkers of Nutrition for Development (BOND): Vitamin B-12 Review. J Nutr 2018; 148(suppl_4): 1995S–2027S. DOI:10.1093/jn/nxy201; Кондратьева Е.И., Янкина Г.Н., Лошкова Е.В. Различные варианты непереносимости белка пшеницы. Современные представления. Вопросы диетологии 2016; 3: 57–66.; Янкина Г.Н., Кондратьева Е.И., Лошкова Е.В., Терентьева А.А. Особенности диагностики и лечения различных форм непереносимости белка пшеницы. Вопросы детской диетологии 2017; 15(1): 13–24.; Wolffenbuttel B.R., Wouters H.M., Heiner-Fokkema M.R., van der Klauw M.M. The Many Faces of Cobalamin (Vitamin B12) Deficiency. Mayo Clin Proc Innov Qual Outcomes 2019; 3(2): 200–214. DOI:10.1016/j.mayocpiqo.2019.03.002; Balaban D.V., Popp A., Ionita Radu F., Jinga M. Hematologic Manifestations in Celiac Disease-A Practical Review. Medicina (Kaunas) 2019; 55(7): 373. DOI:10.3390/medicina55070373; Green R., Allen L.H., Bjørke-Monsen A.L., Brito A., Guéant J.L., Miller J.W. et al. Vitamin B12 deficiency. Nat Rev Dis Primers 2017; 3: 17040. DOI:10.1038/nrdp.2017.40; Robea M.A., Luca A.C., Ciobica A. Relationship between Vitamin Deficiencies and Co-Occurring Symptoms in Autism Spectrum Disorder. Medicina (Kaunas) 2020; 56(5): 245. DOI:10.3390/medicina56050245; Wong C.W., Ip C.Y., Leung C.P., Leung C.S., Cheng J.N., Siu C.Y. Vitamin B12 deficiency in the institutionalized elderly: a regional study. Exp Gerontol 2015; 69: 221–225. DOI:10.1016/j.exger.2015.06.016; Yildirim T., Yalcin A., Atmis V. The prevalence of anemia, iron, vitamin B12, and folic acid deficiencies in community dwelling elderly in Ankara, Turkey. Arch Gerontol Geriatr 2015; 60(2): 344–348. DOI:10.1016/j.archger.2015.01.001; Vrkljan A.M., Pašaliü A., Strinoviü M., Periü B., Kruljac I., Miroševü G. Coexistence of Addison’s disease and pernicious anemia: is the new classification of autoimmune polyglandular syndrome appropriate? Acta Clin Croat 2015; 54(2): 232–235; Molloy A.M. Should vitamin B12 status be considered in assessing risk of neural tube defects? Ann N Y Acad Sci 2018; 1414(1): 109–125. DOI:10.1111/nyas.13574; Rogne T., Tielemans M.J., Chong M.F. Associations of maternal vitamin B 12 concentration in pregnancy with the risks of preterm birth and low birth weight: a systematic review and meta-analysis of individual participant data. Am J Epidemiol 2017; 185(3): 212–223. DOI:10.1093/aje/kww212; McKay J.A., Groom A., Potter C. Genetic and non-genetic influences during pregnancy on infant global and site-specific DNA methylation: role for folate gene variants and vitamin B12. PloS One 2012; 7(3): e33290. DOI:10.1371/journal.pone.0033290; Obeid R., Murphy M., Solé-Navais P., Yajnik C. Cobalamin status from pregnancy to early childhood: lessons from global experience. Adv Nutr 2017; 8(6): 971–979. DOI:10.3945/an.117.015628; Kvestad I., Hysing M., Shrestha M. Vitamin B-12 status in infancy is positively associated with development and cognitive functioning 5 y later in Nepalese children. Am J Clin Nutr 2017; 105(5): 1122–1131. DOI:10.3945/ajcn.116.144931; Roman-Garcia P., Quiros-Gonzalez I., Mottram L. Vitamin B12-dependent taurine synthesis regulates growth and bone mass. J Clin Invest 2014; 124(7): 2988–3002. DOI:10.1172/JCI72606; Национальная программа оптимизации вскармливания детей первого года жизни в Российской Федерации (4-е издание, переработанное и дополненное). Союз педиатров России [и др.]. М.: ПедиатрЪ, 2019; 206.; Национальная программа оптимизации питания детей в возрасте от 1 года до 3 лет в Российской Федерации (4-е издание, переработанное и дополненное). Союз педиатров России [и др.]. М.: ПедиатрЪ, 2016; 36.; Федеральные клинические рекомендации по оказанию помощи детям с пищевой аллергией. М.: ПедиатрЪ, 2016: 27.; https://www.ped-perinatology.ru/jour/article/view/1493

الاتاحة: https://www.ped-perinatology.ru/jour/article/view/1493
https://doi.org/10.21508/1027-4065-2021-66-5-135-14

المؤلفون: I. V. Mikhalenko, E. V. Mikhalev, И. В. Михаленко, Е. В. Михалев

المصدر: Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics); Том 59, № 2 (2014); 61-65 ; Российский вестник перинатологии и педиатрии; Том 59, № 2 (2014); 61-65 ; 2500-2228 ; 1027-4065 ; undefined

مصطلحات موضوعية: пьезоэлектрическая гемовиско-зиметрия, hemostasis, endothelial dysfunction, hypoxic central nervous system injury, piezoelectric blood viscometry, гемостаз, эндотелиальная дисфункция, поражение ЦНС

وصف الملف: application/pdf

Relation: https://www.ped-perinatology.ru/jour/article/view/207/247; Михалев Е.В., Филиппов Т.П., Ермоленко СП. Онтогенетические особенности гемостаза у новорожденных детей. Анестезиология и реаниматология 2003; 1: 28—30. (Mikhalev E.V., Filippov, G.P., Ermolenko S.P. Ontogenetical characteristics of hemostasis in newborns. Anesteziologiya ireanimatologiya2003; 1: 28—30.); Shibuya M. Vascular endothelial growth factor receptor-1: a dual regulator for angiogenesis. Angiogenesis 2006; 9: 225—230.; Tsutsumi Y., Losordo D. W. Double face of VEGF. Circulation 2005; 112: 1248-1250.; Шиффман Ф.Дж. Патофизиология крови. Москва — Санкт-Петербург: «БИНОМ» — «Невский Диалект» 2000; 448. (SchiffmanFJ. Pathophysiology of blood. Moscow — St-Petersburg: «BINOM» — «NevskyDialect» 2000; 448.); МихалевЕ.В., Ермоленко СП., Филиппов Т. П. и dp. Система гемостаза у недоношенных новорожденных с внутриже-лудочковыми кровоизлияниями, осложненными гнойным менингитом. Рос вестн перинатол и педиат 2004; 3: 10—14. (Mikhalev E.V., Ermolenko S.P, Filippov G.P etal. Hemostatic system in preterm infants with intraventricular hemorrhage complicated by purulent meningitis. Ros vestn perinatal ipediat 2004; 3: 10—14.); Алиева Л.Б. Современные представления о системе гемостаза у новорожденных детей. Рос вестн перинатол и педиат 2010; 5: 19—23. (Alieva L.B. Modern views on the hemostatic system in newborn infants. Ros vestn perinatal ipediat2010;5: 19—23.); https://www.ped-perinatology.ru/jour/article/view/207; undefined

الاتاحة: https://www.ped-perinatology.ru/jour/article/view/207

المؤلفون: I. V. Mikhalenko, E. V. Mikhalev, S. P. Ermolenko, И. В. Михаленко, Е. В. Михалев, С. П. Ермоленко

المصدر: Pediatric pharmacology; Том 10, № 4 (2013); 113-117 ; Педиатрическая фармакология; Том 10, № 4 (2013); 113-117 ; 2500-3089 ; 1727-5776

مصطلحات موضوعية: гипоксическое поражение ЦНС, VEGF, NSE, BDNF, hypoxic brain injury

وصف الملف: application/pdf

Relation: https://www.pedpharma.ru/jour/article/view/202/288; Martin J. A., Kung H. C., Mathews T. J. et al. Annual summary of vital statistics. Pediatrics. Apr 2008; 121 (4): 788–801.; Огородова Л. М., Белевский А. С., Куликов Е. С., Петровский Ф. И., Деев И. А., Чучалин А. Г. Сравнительная эффективность стратегий достижения контроля в условиях реальной клинической практики: данные многоцентрового исследования «Стрела». Пульмонология. 2009; 6: 69–77.; Terzic S., Heljic S. Assessing mortality risk in very low birth weight infants. Med Arh. 2012; 66 (2): 76–79.; Saigal S., Stoskopf B., Streiner D. et al. Growth trajectories of extremely low birth weight infants from birth to young adulthood: a longitudinal, population based study. Pediatr Res. 2006; 60: 751–758.; Кулаков В. И., Антонов А. Г., Байбарина Е. Н. Проблемы и перспективы выхаживания детей с экстремально низкой массой тела на современном этапе. Российский вестник перинатологии и педиатрии. 2006; 4: 8–11.; University of Alabama at Birmingham (2013, April 1). Prematurity, low birth weight significantly impact mortality rates. Science Daily. Retrieved June 10, 2013.; Farooqi A., Hagglof B., Sedin G., Serenius F. Impact at age 11 years of major neonatal morbidities in children born extremely preterm. Pediatrics. May 2011; 127 (5): 1247–57.; Намазова-Баранова Л.С. Научные исследования и инфраструктура платформы «Педиатрия». Педиатрическая фармакология. 2012; 9 (4): 15–24.; https://www.pedpharma.ru/jour/article/view/202

الاتاحة: https://www.pedpharma.ru/jour/article/view/202
https://doi.org/10.15690/pf.v10i4.762